Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 May 26;16(8):1165–1166. doi: 10.1016/j.soard.2020.05.020

Open letter to insurance companies regarding mandatory in-office visit weight documentation in an era of COVID-19

Matthew M Hutter 1, Shanu N Kothari 2,, Teresa L LaMasters 3, Eric J DeMaria 4
PMCID: PMC7255233  PMID: 32620376

To: Insurance Company, Medical Director

From: American Society for Metabolic and Bariatric Surgery (ASMBS)

Re: Mandatory prebariatric surgery diet regimens and in-office weights

During these unprecedented times with the coronavirus disease 2019 (COVID-19) pandemic, it has become clear that some populations are at increased risk of severe illness, complications, and death once contracting the novel coronavirus. This is particularly the case for patients with obesity and type 2 diabetes [[1], [2], [3], [4], [5]]. Treatment of people with the disease of obesity and related disease is critical in the strategy to decrease risk of poor outcomes and death following COVID-19. Metabolic and/or bariatric surgery is the only proven long-term successful intervention for patients with clinically severe obesity. In addition, there are more than 12 prospective, randomized trials showing the superiority of metabolic and/or bariatric surgery over optimal medical management for patients with type 2 diabetes [6,7]. Increased morbidity and mortality due to coronavirus infection is only the newest of several hundred medical co-morbid conditions caused or aggravated by obesity including some of the most serious diseases impacting our society today, such as type 2 diabetes, hypertension, heart disease, and obesity-related cancers.

Currently there are multiple insurance-mandated barriers to care that are placed on people seeking treatment of severe obesity. One of these barriers relates to specific diet- and weight-related requirements. This typically includes regular in-office weight measurements and in some cases the requirement for documentation of weight loss before receiving surgical treatment for the disease of obesity. Based on data from multiple studies that show no benefit to insurance-mandated documentation of diet effort and/or weight loss before metabolic/bariatric surgery, as summarized by the ASMBS Clinical Issues Committee in our peer-reviewed publication from 2016 [8], we recommend immediate termination of all insurance-mandated diet- and weight-related prerequisites for bariatric surgery, including the excessive, burdensome, and potentially dangerous requirement for in-office weight documentation. These requirements not only have no scientific basis to support their existence, but they also create barriers to care [[9], [10], [11], [12], [13], [14], [15], [16]]. Furthermore, by requiring in-person visits to accomplish repeated weight checks, these requirements lead to unnecessary healthcare facility visits for some of our most vulnerable patients, putting them at increased risk for exposure to and transmission of COVID-19.

The best preoperative care and preparation for surgery is determined at the local level by the multidisciplinary team caring for their patients on the front lines [8]. Many healthcare providers and patients are finding telehealth solutions in the current environment that allow for effective care without the risks incurred by in-office visits.

In recent weeks, the U.S. healthcare system has been stressed to unprecedented levels as many healthcare providers have been reassigned, furloughed, or lost their jobs. Adding unnecessary in-person appointments and presurgical weight loss requirements will only stress the system further in a time of scarce resources. Consequently, we feel there is no better time than the present for health plans to use evidence-based recommendations and terminate these unsubstantiated discriminatory policies.

We look forward to working together to create a safe and effective strategy for presurgical care and preparation for patients pursing surgical management of the disease of severe obesity.

Disclosures

The authors have no commercial associations that might be a conflict of interest in relation to this article.

References

  • 1.Wu C, Chen X, Cai Y, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. Epub 2020 Mar 13. [DOI] [PMC free article] [PubMed]
  • 2.Guan W.J., Ni Z.Y., Hu Y. China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi: 10.1056/NEJMoa2002032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Cai Q, Chen F, Wang T, et al. Obesity and COVID-19 severity in a designated hospital in Shenzhen, China. Diabetes Care. Epub 2020 May 14. [DOI] [PubMed]
  • 4.Centers for Disease Control and Prevention [homepage on the Internet] Coronavirus disease 2019 (COVID-19): people who are at higher risk for severe illness. 2020 [updated 2020 May 14; cited 2020 Apr 08] https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-at-higher-risk.html Available from:
  • 5.Garg S., Kim L., Whitaker M. Hospitalization rates and characteristics of patients hospitalized with laboratory-confirmed coronavirus disease 2019 - COVID-NET, 14 states, March 1-30, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(15):458–464. doi: 10.15585/mmwr.mm6915e3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Khorgami Z., Shoar S., Saber A.A., Howard C.A., Danaei G., Sclabas G.M. Outcomes of bariatric surgery versus medical management for type 2 diabetes mellitus: a meta-analysis of randomized controlled trials. Obes Surg. 2019;29(3):964–974. doi: 10.1007/s11695-018-3552-x. [DOI] [PubMed] [Google Scholar]
  • 7.Müller-Stich B.P., Senft J.D., Warschkow R. Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis. Ann Surg. 2015;261(3):421–429. doi: 10.1097/SLA.0000000000001014. [DOI] [PubMed] [Google Scholar]
  • 8.Kim J.J., Rogers A.M., Ballem N., Schirmer B., American Society for Metabolic and Bariatric Surgery Clinical Issues Committee ASMBS updated position statement on insurance mandated preoperative weight loss requirements. Surg Obes Relat Dis. 2016;12(5):955–959. doi: 10.1016/j.soard.2016.04.019. [DOI] [PubMed] [Google Scholar]
  • 9.Janz E., Larson C.J., Methiason M.A., Kallies K.J., Kothari S.N. Number of weight loss attempts and maximum weight loss before Roux-en-Y laparoscopic gastric bypass surgery are not predictive of postoperative weight loss. Surg Obes Relat Dis. 2009;5(2):208–211. doi: 10.1016/j.soard.2008.08.015. [DOI] [PubMed] [Google Scholar]
  • 10.Jamal M.K., DeMaria E.J., Johnson J.M. Insurance-mandated preoperative counseling does not improve outcome and increases dropout rate in patients considering gastric bypass for morbid obesity. Surg Obes Relat Dis. 2006;2(2):122–127. doi: 10.1016/j.soard.2006.01.009. [DOI] [PubMed] [Google Scholar]
  • 11.Harakeh A.B., Burkhamer K.J., Kallies K.J., Mathiason M.A., Kothari S.N. The natural history and metabolic consequences of morbid obesity for patients denied coverage for bariatric surgery. Surg Obes Relat Dis. 2010;6(6):591–596. doi: 10.1016/j.soard.2010.08.012. [DOI] [PubMed] [Google Scholar]
  • 12.Keith C.J., Jr., Goss L.E., Blackledge C.D., Stahl R.D., Grams J. Insurance-mandated preoperative diet and outcomes after bariatric surgery. Surg Obes Relat Dis. 2018;14(5):631–636. doi: 10.1016/j.soard.2018.01.017. [DOI] [PubMed] [Google Scholar]
  • 13.Schneider A., Hutcheon D.A., Hale A., Ewing J.A., Miller M., Scott J.D. Postoperative outcomes in bariatric surgical patients participating in an insurance-mandated preoperative weight management program. Surg Obes Relat Dis. 2018;14(5):623–630. doi: 10.1016/j.soard.2018.01.036. [DOI] [PubMed] [Google Scholar]
  • 14.Kim J.J. Evidence base for optimal preoperative preparation for bariatric surgery: does mandatory weight loss make a difference? Curr Obes Rep. 2017;6(3):238–245. doi: 10.1007/s13679-017-0269-4. [DOI] [PubMed] [Google Scholar]
  • 15.Horwitz D., Saunders J.K., Ude-Welcome A., Parikh M. Insurance-mandated medical weight management before bariatric surgery. Surg Obes Relat Dis. 2016;12(3):496–499. doi: 10.1016/j.soard.2015.09.004. [DOI] [PubMed] [Google Scholar]
  • 16.Kuwada T.S., Richardson S., El Chaar M. Insurance-mandated medical programs before bariatric surgery: do good things come to those who wait? Surg Obes Relat Dis. 2011;7(4):526–530. doi: 10.1016/j.soard.2010.08.017. [DOI] [PubMed] [Google Scholar]

Articles from Surgery for Obesity and Related Diseases are provided here courtesy of Elsevier

RESOURCES